Kotaro Hasegawa

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography

Yuji Ikari, Cees Vermeer, P.E.P. Dissel et al. · Thrombosis and Haemostasis · 2004 · 136 citations

Medicine, Cardiology, Molecular Genetics +12

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Three-dimensional echocardiography by semi-automatic border detection in assessment of left ventricular volume and ejection fraction: comparison with magnetic resonance imaging.

Masatsugu Iwase, Takeshi Kondo, Kotaro Hasegawa et al. · PubMed · 1997 · 26 citations

Medicine, Cardiology, Radiology +17

Sirolimus Eluting Coronary Stent Implantation in Patients on Maintenance Hemodialysis

Yuji Ikari, Kengo Tanabe, Yutaka Koyama et al. · Circulation Journal · 2012 · 18 citations · Full text

Medicine, Cardiology, Nephrology +17